Correspondence 0001213900-24-056630 from ABVC BIOPHARMA, INC. (ABVC) (CIK 0001173313) (ABVC)
ABVC BIOPHARMA, INC. (ABVC) (CIK 0001173313)
Date: June 27, 2024 · CIK: 0001173313 · Accession: 0001213900-24-056630
AI Filing Summary & Sentiment
File numbers found in text: 333-280411
Letter
ABVC BioPharma, Inc.
44370 Old Warm Springs Blvd.,
Fremont, CA 94538
VIA EDGAR
June 27, 2024
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Mail Stop 3561
Washington, D.C. 20549
Attn: Mr. Jason Drory
Re:
ABVC BioPharma, Inc.
Registration Statement on Form S-1
File No. 333-280411
Filed on: June 21, 2024
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, ABVC BioPharma Inc., a Nevada corporation (the “Company”), hereby requests that the effective date of the above-referenced registration statement on Form S-1, as amended, be accelerated so that it will become effective at 4:00 p.m. Eastern Time on July 1, 2024 or as soon thereafter as practicable.
Very truly yours,
/s/ Uttam Patil
Show Raw Text
CORRESP
1
filename1.htm
ABVC BioPharma, Inc.
44370 Old Warm Springs Blvd.,
Fremont, CA 94538
VIA EDGAR
June 27, 2024
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Mail Stop 3561
Washington, D.C. 20549
Attn: Mr. Jason Drory
Re:
ABVC BioPharma, Inc.
Registration Statement on Form S-1
File No. 333-280411
Filed on: June 21, 2024
Ladies and Gentlemen:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended, ABVC BioPharma Inc., a Nevada corporation (the “Company”),
hereby requests that the effective date of the above-referenced registration statement on Form S-1, as amended, be accelerated so that
it will become effective at 4:00 p.m. Eastern Time on July 1, 2024 or as soon thereafter as practicable.
Very truly yours,
/s/ Uttam Patil
Uttam Patil
Chief Executive Officer